Health Canada inspection
Orient Pharma Co., Ltd.: Health Canada inspection of Nov 16, 2018
Health Canada · GMP · rating C
Key facts
| Establishment | Orient Pharma Co., Ltd. |
|---|---|
| City | Huwei Chen |
| Province | Yunlin |
| Country | Taiwan |
| Program | GMP |
| Start date | Nov 12, 2018 |
| End date | Nov 16, 2018 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.